Chemtura (CHMT) Reports In-Line Q2 EPS

Chemtura (NYSE: CHMT) reported Q2 EPS of $0.29, in-line with the analyst estimate of $0.29. Revenue for the quarter came in at $464 million versus the consensus estimate of $479.14 million.

For earnings history and earnings-related data on Chemtura (CHMT) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat